A detailed history of J. Safra Sarasin Holding Ag transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, J. Safra Sarasin Holding Ag holds 31,369 shares of ITCI stock, worth $2.86 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
31,369
Holding current value
$2.86 Million
% of portfolio
0.04%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

BUY
$64.76 - $79.84 $2.03 Million - $2.5 Million
31,369 New
31,369 $2.15 Billion

Others Institutions Holding ITCI

About Intra-Cellular Therapies, Inc.


  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $8.62B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track J. Safra Sarasin Holding Ag Portfolio

Follow J. Safra Sarasin Holding Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of J. Safra Sarasin Holding Ag, based on Form 13F filings with the SEC.

News

Stay updated on J. Safra Sarasin Holding Ag with notifications on news.